Al Nahdi Medical Company SCJSC
SAU:4164
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
127
153.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Al Nahdi Medical Company SCJSC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | SA |
Market Cap | 16.8B SAR |
Net Margin |
9%
|
Country | ZA |
Market Cap | 98.2B Zac |
Net Margin |
6%
|
Country | ZA |
Market Cap | 31.9B Zac |
Net Margin |
3%
|
Country | BR |
Market Cap | 44.6B BRL |
Net Margin |
3%
|
Country | US |
Market Cap | 7.5B USD |
Net Margin |
-6%
|
Country | JP |
Market Cap | 845.2B JPY |
Net Margin |
5%
|
Country | CN |
Market Cap | 27.3B CNY |
Net Margin |
6%
|
Country | MX |
Market Cap | 70.6B MXN |
Net Margin |
4%
|
Country | JP |
Market Cap | 547.7B JPY |
Net Margin |
3%
|
Country | NL |
Market Cap | 2.9B EUR |
Net Margin |
-1%
|
Country | JP |
Market Cap | 457.5B JPY |
Net Margin |
3%
|
Al Nahdi Medical Company SCJSC
Glance View
Nahdi Medical Co. operates pharmacy stores. The company is headquartered in Jeddah, Makkah. The company went IPO on 2022-03-22. The firm is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods and medical equipment. The firm operates two operating segments: Front Shop and Pharma. The firm provides medicine, wellness, mom & baby, beauty and other wide-ranging FMCG products. The firm provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. The firm operates approximately 1,150 stores in 144 cities and towns in the Kingdom of Saudi Arabia and the United Arab Emirates. The Company’s subsidiaries include Al Nahdi Care, Sakhaa Golden Company, and Nahdi Investment Company.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Al Nahdi Medical Company SCJSC's most recent financial statements, the company has Net Margin of 9.5%.